Higher Fibrinogen Levels Predict Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 671-673

  Rodrigues, T C ^a,b   Snell Bergeon, J K ^a   Maahs, D M ^a   Kinney, G L ^a   Rewers, M ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Coronary artery calcification; Fibrinogen; Type 1 diabetes

Indexed keywords

FIBRINOGEN;

ADULT; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; CALCINOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953230630     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.034     Document Type: Article

References (15)

1. Soedamah-Muthu S.S., Chatuverdi N., Pickup J.C., et al. Relationship between plasma sialic acid fibrinogen concentration and incident micro-and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS). Diabetologia 2008, 51:493-501.
2. Klein R.L., Hunter S.J., Jenkins A.J., et al. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes. Diabetes Care 2003, 26:1439-1448.
3. Lowe G.D., Rumley A. Fibrinogen and its degradation products as thrombotic risk factors. Ann N Y Acad Sci 2001, 936:560-565.
4. Mendall M.A., Patel P., Ballam L., et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996, 312:1061-1065.
5. Green D., Foiles N., Chan C., et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The Cardia Study. Atherosclerosis 2009, 202:623-631.
6. Dabelea D., Kinney G., Snell-Bergeon J.K., et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. Diabetes 2003, 52:2833-2839.
7. Maahs D.M., Ogden L.G., Kretowski A., et al. Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1. Diabetes 2007, 56:2774-2779.
8. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
9. Callister T.Q., Cooil B., Raya S.P., et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998, 208:807-814.
10. Hokanson J.E., Mackenzie T., Kinney G., et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. Am J Roentgenol 2004, 182:1327-1332.
11. Sadoshima S., Tanaka K. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 1979, 34:93-103.
12. Smith E.B., Staples E.M., Dietz H.S., Smith R.H. Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi, and graft pseudo-intimas. Lancet 1979, 2:812-816.
13. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997, 96:1102-1108.
14. Bielak L.F., Klee G.G., Sheedy P.F., et al. Association of Fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography. Thromb Vasc Biol 2000, 20:2167-2171.
15. Jenny NS, Brown ER, Detrano R, et al. Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009, Epub ahead of print.